
Aditya Birla Sun Life AMC Analyst Review 2027: Three Positive Calls, Targets Up to ₹1,150 and a 2.75% Yield
Updated: 18 Nov 2026 • 9:38 am
Posted by:

Aditya Birla Sun Life AMC Stock Snapshot (17 Nov 2026 close)
- Current Market Price (CMP): ₹924.15
- 52-Week High / Low: ₹1,224.90 / ₹708.00
- Market Capitalisation: ₹26,754 crore
- P/E Ratio vs Industry P/E: 27.1 vs 17.9
- Latest Quarter (Q2 FY27) Revenue: ₹526.19 crore
- Latest Quarter (Q2 FY27) Net Profit: ₹220.98 crore
Quick Answer: The Aditya Birla Sun Life AMC analyst review 2027 is broadly positive. After Q2 FY27 results in October 2026, Emkay kept ADD with a ₹1,150 target, Elara Capital rated it Accumulate with a ₹1,100 target and PL Capital kept a Buy rating. Those targets sit about 19% to 24% above the 17 November close of ₹924.15. Total income rose about 4% to ₹526.19 crore, while profit eased about 8% to ₹220.98 crore. The Aditya Birla Sun Life AMC share price target 2027 rests on equity market share stabilising and the flagship funds regaining flows.
The Aditya Birla Sun Life AMC analyst review 2027 covers one of India's larger listed fund houses, promoted by Aditya Birla Capital and Sun Life of Canada. Investors searching for an Aditya Birla Sun Life AMC share price target 2027 will find three recent brokerage calls, all positive, with targets clustered between ₹1,100 and ₹1,150.
Aditya Birla Sun Life AMC closed at ₹924.15 on 17 November 2026, about 25% below its 52-week high of ₹1,224.90 and about 31% above its low of ₹708. This Aditya Birla Sun Life AMC analyst review 2027 covers what analysts expect, how the quarter played out and the Aditya Birla Sun Life AMC stock outlook 2027.
Click Here – Get Free Investment Predictions
What Brokerages Say in the Aditya Birla Sun Life AMC Analyst Review 2027
| Brokerage | Rating | Target Price | Date |
|---|---|---|---|
| Emkay Global | ADD | ₹1,150 (Sep 2027) | October 2026 |
| Elara Capital | Accumulate | ₹1,100 | October 2026 |
| PL Capital (Prabhudas Lilladher) | Buy | Not disclosed in public summary | October 2026 |
Emkay described Q2 FY27 as a largely in-line performance and said flagship funds are gaining traction. It kept FY27 estimates largely unchanged, raised FY28 and FY29 profit estimates by about 4% to 5%, and kept its ₹1,150 target for September 2027, implying about 28 times FY28 earnings. That target is about 24% above the current price.
PL Capital said core income beat its estimate on better revenue yields and noted that one-year equity fund performance has been improving. It trimmed FY27 core EPS slightly for higher ESOP costs and kept a Buy rating, calling net equity flow market share the key to a re-rating. Elara Capital rated the stock Accumulate with a ₹1,100 target, about 19% above the market price.
For the Aditya Birla Sun Life AMC analyst review 2027, the common thread across all three brokerage notes is that fund performance is improving and the stock has room to recover if flows follow.
Q2 FY27 Results in the Aditya Birla Sun Life AMC Analyst Review 2027
| Quarter | Total Income | EBITDA | Net Profit |
|---|---|---|---|
| Sep 2026 (Q2 FY27) | ₹526.19 crore | ₹310.43 crore | ₹220.98 crore |
| Jun 2026 (Q1 FY27) | ₹625.35 crore | ₹420.02 crore | ₹309.49 crore |
| Mar 2026 (Q4 FY26) | ₹425.37 crore | ₹233.56 crore | ₹187.11 crore |
| Dec 2025 (Q3 FY26) | ₹562.40 crore | ₹371.20 crore | ₹269.52 crore |
| Sep 2025 (Q2 FY26) | ₹506.47 crore | ₹327.72 crore | ₹241.32 crore |
Total income rose about 3.9% from a year earlier to ₹526.19 crore. Net profit fell about 8.4% to ₹220.98 crore, and it was well below the strong June quarter. Total income for an AMC includes treasury gains, which swing with markets, so quarterly profit can move more than the core fee business.
The fee base held up. Equity mutual fund AUM rose about 9% to about ₹2.09 lakh crore, and passive AUM rose about 10% to about ₹39,900 crore. In the Aditya Birla Sun Life AMC analyst review 2027, analysts are focused on that core income line, which PL Capital said beat expectations.
How Aditya Birla Sun Life AMC Makes Money
The company earns management fees as a percentage of the money it manages across mutual funds and other mandates.
- Equity funds: the highest-fee category, so equity AUM drives most of the profit.
- Debt and liquid funds: large in size but earn lower fees.
- Passive funds: index funds and ETFs, a fast-growing but low-fee segment.
- Alternates and mandates: portfolio management, alternative funds and institutional mandates, including private retirement and overseas money.
- Treasury income: returns on the company's own investments, which add volatility.
Annual revenue rose to about ₹2,059.5 crore in FY26 from ₹1,640.6 crore in FY24, and profit rose to about ₹975.1 crore from ₹780.4 crore. Operating cash flow of about ₹812 crore in FY26 supports a high payout, which is why the Aditya Birla Sun Life AMC analyst review 2027 treats the dividend as part of the return case.
Growth Triggers in the Aditya Birla Sun Life AMC Analyst Review 2027
- Fund performance: improving one-year returns in equity schemes can pull back flows, the main hope in the Aditya Birla Sun Life AMC analyst review 2027.
- Flagship traction: Emkay noted that the larger flagship funds are gaining traction.
- Passive and alternates: passive AUM grew about 10% and new mandates widen the fee base.
- Dividend yield: a yield of about 2.75% is high for the sector.
- Domestic support: domestic institutions raised their stake to 15.07% from 10.30% in a year, a clear signal in the Aditya Birla Sun Life AMC analyst review 2027.
Key Risks in the Aditya Birla Sun Life AMC Analyst Review 2027
- Market share: the company lost equity market share over several years, and recovery is not yet proven in the Aditya Birla Sun Life AMC analyst review 2027.
- Profit volatility: Q2 FY27 profit fell about 8% as treasury income swung.
- Market dependence: a fall in equity markets cuts AUM and fee income.
- Fee pressure: regulators and competition keep pushing expense ratios down, a sector-wide risk in the Aditya Birla Sun Life AMC analyst review 2027.
- Cost increases: higher ESOP costs led PL Capital to trim FY27 estimates.
- Foreign selling: foreign investors cut their stake to 4.32% from 6.18%.
Compare Aditya Birla Sun Life AMC With Listed AMC Stocks on the Univest Screener
Aditya Birla Sun Life AMC Analyst Review 2027: Stock at a Glance
| Metric | Value |
|---|---|
| Share Price (17 Nov 2026 close) | ₹924.15 |
| 52-Week High / Low | ₹1,224.90 / ₹708.00 |
| Market Capitalisation | ₹26,754 crore |
| P/E (TTM) vs Industry | 27.1 vs 17.9 |
| Price to Book | 6.89 |
| Book Value per Share | ₹134.12 |
| Return on Equity | 25.43% |
| Debt to Equity | 0.02 |
| Dividend Yield | 2.75% |
| FY26 Revenue / Net Profit | ₹2,059.5 crore / ₹975.1 crore |
A P/E near 27 is above the broad industry figure but lower than many listed fund house peers have traded at in strong markets. Near-zero debt to equity, a 25% return on equity and a price to book value near 6.9 make the Aditya Birla Sun Life AMC analyst review 2027 a story about flows rather than balance sheet risk.
Shareholding Trend
| Holder | Sep 2025 | Sep 2026 | Change |
|---|---|---|---|
| Promoters | 74.85% | 74.67% | -0.18 pts |
| Foreign Investors (FII) | 6.18% | 4.32% | -1.86 pts |
| Domestic Institutions (DII) | 10.30% | 15.07% | +4.77 pts |
| Public | 8.66% | 5.94% | -2.72 pts |
The promoter group is led by Aditya Birla Capital at 44.80% and Sun Life (India) AMC Investments at 29.87%. Domestic institutions added nearly five percentage points over the year, more than offsetting foreign and retail selling. That shift in ownership is a quiet positive in the Aditya Birla Sun Life AMC analyst review 2027.
What to Watch After the Aditya Birla Sun Life AMC Analyst Review 2027
- Net equity flows: PL Capital calls equity flow market share the key to a re-rating.
- Fund performance: whether one-year returns in flagship schemes keep improving.
- Core income: fee income trends, separate from treasury gains.
- Payouts: dividends that support the 2.75% yield.
- Target revisions: updates to the ₹1,100 and ₹1,150 targets would shift the Aditya Birla Sun Life AMC share price target 2027 range.
Final Word on the Aditya Birla Sun Life AMC Analyst Review 2027
The Aditya Birla Sun Life AMC analyst review 2027 shows a profitable, debt-free fund house with improving fund performance and three positive brokerage calls. Q2 FY27 profit was softer, but the core fee business held up and equity AUM grew about 9%.
The Aditya Birla Sun Life AMC stock outlook 2027 depends on whether better performance turns into higher equity flows and market share. Univest does not give a buy or sell call.
Disclaimer: This article is for educational and informational purposes only and is not investment advice or a recommendation to buy, sell or hold any security. Brokerage ratings and target prices quoted here are opinions of third-party research houses; Univest does not endorse them and gives no buy or sell call. Investments in the securities market are subject to market risks. Read all related documents carefully before investing. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.
Frequently Asked Questions
What does the Aditya Birla Sun Life AMC analyst review 2027 show?
It shows three positive brokerage calls after Q2 FY27 results. Emkay has ADD at ₹1,150, Elara Capital has Accumulate at ₹1,100 and PL Capital has a Buy rating. The stock closed at ₹924.15 on 17 November 2026.
What is the Aditya Birla Sun Life AMC share price target 2027 from brokerages?
Emkay has a ₹1,150 target for September 2027 and Elara Capital has a ₹1,100 target, both set in October 2026. These imply about 24% and 19% upside from ₹924.15. PL Capital kept its Buy rating in the same month.
How did Aditya Birla Sun Life AMC perform in Q2 FY27?
Total income rose about 3.9% to ₹526.19 crore. Net profit fell about 8.4% to ₹220.98 crore. Equity mutual fund AUM rose about 9% to about ₹2.09 lakh crore.
Why did profit fall even though income rose?
An AMC's total income includes treasury gains on its own investments, which swing with markets. The core fee business held up, and PL Capital said core income beat its estimate. Profit was ₹220.98 crore against ₹241.32 crore a year earlier.
Does Aditya Birla Sun Life AMC pay a good dividend?
The dividend yield is about 2.75%, high for a listed financial company. The business has near-zero debt and generated about ₹812 crore of operating cash flow in FY26. Return on equity is 25.43%.
What risks does the Aditya Birla Sun Life AMC analyst review 2027 highlight?
The main risks are past loss of equity market share, profit swings from treasury income and dependence on equity markets. Foreign investors cut their stake to 4.32% from 6.18%. Fee pressure across the industry is another factor.
What should investors track after the Aditya Birla Sun Life AMC analyst review 2027?
Track net equity flows and market share, which PL Capital calls the key to a re-rating. Watch one-year performance of flagship equity funds. Updates to the ₹1,100 and ₹1,150 targets will also matter.
Recent Articles

Andhra Paper Analyst Review 2027: Back to Profit in Q2, Stock at 0.64 Times Book and a Pollution Penalty Under Appeal
18 November 2026

Amrutanjan Analyst Review 2027: Q2 Profit Up 24%, Hygiene Grows Fast and the Stock Sits Near Its Low
18 November 2026

Amines and Plasticizers Analyst Review 2027: Profit Up 35% in Q2, Thin Margins and Zero Institutional Holding
18 November 2026

Alok Industries Analyst Review 2027: Revenue Up 15%, Loss Widens to ₹208 Crore and Net Worth Stays Negative
18 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Andhra Paper Analyst Review 2027: Back to Profit in Q2, Stock at 0.64 Times Book and a Pollution Penalty Under Appeal
Amrutanjan Analyst Review 2027: Q2 Profit Up 24%, Hygiene Grows Fast and the Stock Sits Near Its Low
Amines and Plasticizers Analyst Review 2027: Profit Up 35% in Q2, Thin Margins and Zero Institutional Holding
Alok Industries Analyst Review 2027: Revenue Up 15%, Loss Widens to ₹208 Crore and Net Worth Stays Negative
Allied Digital Analyst Review 2027: Revenue Up 14%, Profit Down 18% and the Stock Below Book Value
Popular this week
Allcargo Logistics Analyst Review 2027: A Smaller, Domestic Company After the Split, With Profit Back at ₹18 Crore

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





